top of page
  • Shashi

China Creating National Medical Ethics Committee

Updated: Apr 12, 2019

Approved by President Xi Jinping, a 30-person national ethics committee has been appointed in China to oversee high-risk clinical trials, STAT News reported. The technologies that will be monitored and regulated are considered risky due to moral or safety concerns and include gene editing, cloning, cell therapy, xenotransplantation, mitochondrial replacement, and nanotechnology. Oversight of these medical technologies aims to counter the perception of weak ethics governance many believe led to the controversial “CRISPR babies” program.


Recent Posts

See All

Producing Heart Muscle Cells to Repair Damaged Hearts

Chronic heart failure is the most common reason for hospital admissions and one of the most frequent causes of death in the western world. Scientists around the world are therefore working on strategi

Stem Cell Therapy for Autoimmune Diseases

"Autoimmune diseases, chronic in nature, are generally hard to alleviate. Present long-term treatments with available drugs such as steroids, immune-suppressive drugs, or antibodies have several debil


bottom of page